nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders
|
Resnick, Lawrence M. |
|
1992 |
93 |
2S1 |
p. S11-S20 10 p. |
artikel |
2 |
Clinical experience with a once-daily, extended-release formulation of diltiazem in the treatment of hypertension
|
Graney, William F. |
|
1992 |
93 |
2S1 |
p. S56-S64 9 p. |
artikel |
3 |
Evolution of the treatment of hypertension: What really matters in the 1990s?
|
Hollenberg, Norman K. |
|
1992 |
93 |
2S1 |
p. S4-S10 7 p. |
artikel |
4 |
Hypertension, left ventricular hypertrophy, ventricular ectopy, and sudden death
|
Messerli, Franz H. |
|
1992 |
93 |
2S1 |
p. S21-S26 6 p. |
artikel |
5 |
Hypertensive nephropathy: Is a more physiologic approach to blood pressure control an important concern for the preservation of renal function?
|
Weir, Matthew R. |
|
1992 |
93 |
2S1 |
p. S27-S37 11 p. |
artikel |
6 |
Novel drug-delivery systems for hypertension
|
Prisant, L.Michael |
|
1992 |
93 |
2S1 |
p. S45-S55 11 p. |
artikel |
7 |
Publisher's note
|
|
|
1992 |
93 |
2S1 |
p. iii- 1 p. |
artikel |
8 |
Selecting optimum antihypertensive therapy: Indications for choosing a calcium channel blocker
|
Murphy, Michael B. |
|
1992 |
93 |
2S1 |
p. S38-S44 7 p. |
artikel |
9 |
The evolution of antihypertensive therapy: Current theoretical conditions and individualized treatment options
|
Weber, Michael A. |
|
1992 |
93 |
2S1 |
p. S1-S3 3 p. |
artikel |